-
241
Mechanisms of inflammatory microenvironment formation in cardiometabolic diseases: molecular and cellular perspectives
Published 2025-01-01Subjects: Get full text
Article -
242
Specific therapeutic options for transthyretin amyloidosis
Published 2024-12-01Subjects: Get full text
Article -
243
-
244
Characteristics and Surgical Results of Patients with Hypertrophic Obstructive Cardiomyopathy without Intrinsic Mitral Valve Diseases Undergoing Mitral Subvalvular Procedures during Myectomy
Published 2020-01-01“…Mitral subvalvular procedures have acquired a major role during hypertrophic obstructive cardiomyopathy (HOCM) surgery. However, few studies have focused on characterizing the clinical feature of HOCM patients without intrinsic mitral valve (MV) diseases undergoing mitral subvalvular procedures in addition to myectomy. …”
Get full text
Article -
245
Initial Experience with Sildenafil, Bosentan, and Nitric Oxide for Pediatric Cardiomyopathy Patients with Elevated Pulmonary Vascular Resistance before and after Orthotopic Heart Transplantation
Published 2010-01-01“…Although pulmonary hypertension complicating dilated cardiomyopathy has been shown to be a significant risk factor for graft failure after heart transplantation, the upper limits of pulmonary vascular resistance (PVR) that would contraindicate pediatric heart transplantation are not known. …”
Get full text
Article -
246
Mutation-Specific Phenotypes in hiPSC-Derived Cardiomyocytes Carrying Either Myosin-Binding Protein C Or α-Tropomyosin Mutation for Hypertrophic Cardiomyopathy
Published 2016-01-01“…Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disease, which affects the structure of heart muscle tissue. …”
Get full text
Article -
247
The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD Rats
Published 2014-01-01“…To investigate the effect of beraprost sodium (BPS) on diabetic cardiomyopathy and the underlying mechanism. Methods. …”
Get full text
Article -
248
A Novel Mutation in the CYP11B1 Gene Causes Steroid 11β-Hydroxylase Deficient Congenital Adrenal Hyperplasia with Reversible Cardiomyopathy
Published 2015-01-01“…Six months following treatment, cardiomyopathy disappeared with normal blood pressure and improvement in the skin pigmentation. …”
Get full text
Article -
249
Germline deletion of Rgs2 and/or Rgs5 in male mice does not exacerbate left ventricular remodeling induced by subchronic isoproterenol infusion
Published 2025-01-01Subjects: Get full text
Article -
250
Idiopathic pulmonary fibrosis is a risk factor for cardiovascular disease: potential role of KL-6 and systemic inflammation
Published 2025-01-01Subjects: Get full text
Article -
251
Cardiac manifestation of phenylketonuria in adulthood
Published 2024-12-01Subjects: Get full text
Article -
252
Advances in genetic diagnosis and therapy of hereditary heart disease: a bibliometric review from 2004 to 2024
Published 2025-01-01Subjects: Get full text
Article -
253
A New, Easy-to-Learn, Fear-Free Method to Stop Purring During Cardiac Auscultation in Cats
Published 2025-01-01Subjects: Get full text
Article -
254
A murine model of acute and prolonged abdominal sepsis, supported by intensive care, reveals time-dependent metabolic alterations in the heart
Published 2025-01-01Subjects: Get full text
Article -
255
Primary Terminal Haemochromatosis in a 50 Year-Old Patient
Published 2021-04-01Subjects: Get full text
Article -
256
Whole genome sequencing in early onset advanced heart failure
Published 2025-02-01Subjects: Get full text
Article -
257
Successful Long-Term Use of Eltrombopag in a Patient with Refractory Severe Thrombocytopenia Associated with Chronic Lymphocytic Leukemia That Allowed Oral Anticoagulant Treatment for Severe Cardiomyopathy
Published 2017-01-01“…Here, we report on a patient with CLL-associated ITP, with thrombocytopenia refractory to corticosteroids and intravenous immunoglobulins, in which continuous oral treatment with Eltrombopag allowed initiation and maintenance of an oral anticoagulation treatment with Acenocoumarol that was indicated because of a severe arrhythmogenic cardiomyopathy.…”
Get full text
Article -
258
How do serum cytokine levels change in myocarditis and inflammatory dilated cardiomyopathy relative to healthy individuals? A protocol for a systematic review and meta-analysis
Published 2025-02-01“…Studies meeting the following criteria will be eligible for inclusion: (1) studies involving ‘myocarditis’ or ‘inflammatory dilated cardiomyopathy’ and (2) studies are required to report serum levels of any cytokine. …”
Get full text
Article -
259
Unusual hypertrophic cardiomyopathy: case report of an early onset wild-type ATTR amyloidosis accompanied by a chromosomal duplication involving the MYH6 and MYH7 gene
Published 2025-02-01Subjects: “…hypertrophic cardiomyopathy…”
Get full text
Article -
260
Heart failure in paediatric Crohn’s disease patient – extraintestinal manifestation, concomitant disease or iatrogenic effect?
Published 2024-12-01Subjects: Get full text
Article